Str/581 Wk 4 Individual: Strategic Plan, Part 3: Strategic Evaluation

Strategic Evaluation Students Name University/College Strategic Evaluation Potential Business Level Strategies Personalized Medicine Personalized medicine is one of the trends predicted to revolutionize healthcare in future. Acorda can become more flexible in development of its therapies in order to create personal medicine. This strategy requires that the biotech companies finds ways of accessing personal information of patients. The firms research and development team can utilize the advancements in healthcare information technology to maintain health information of individuals (Ng, Pearson Ball, 2015). In doing this, the biotech organization would lead to better health outcomes as the therapies would be in line with individual needs. Research and Development Research and development is core to therapeutic companies. The effectiveness of the therapies developed is dependent upon the quality of research. On production of a therapy, the producer should conduct further research aimed at developing that therapy to ensure it remains functional as required. Arcoda can focus on building a topnotch research and development team aided by leading biotechnology and highly skilled and experienced personnel. The company would be able to maintain high quality therapies that have no adverse effects to the clients. Such a research and development team can help discover medical technology